Artículos por temáticas

A mitochondrial etiology of Alzheimer and Parkinson disease

Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, Wallace DC.

Biochim Biophys Acta. 2012 May;1820(5):553-64. doi: 10.1016/j.bbagen.2011.08.008. Epub 2011 Aug 16.

Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease

Cassano T, Serviddio G, Gaetani S, Romano A, Dipasquale P, Cianci S, Bellanti F, Laconca L, Romano AD, Padalino I, LaFerla FM, Nicoletti F, Cuomo V, Vendemiale G.

Neurobiol Aging. 2012 Jun;33(6):1121.e1-12. doi: 10.1016/j.neurobiolaging.2011.09.021. Epub 2011 Oct 27.

Twenty years of Alzheimer's disease-causing mutations

Goate A, Hardy J.

J Neurochem. 2012 Jan;120 Suppl 1:3-8. doi: 10.1111/j.1471-4159.2011.07575.x. Epub 2011 Nov 28.

Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised

Fjell AM, Walhovd KB.

Mol Neurobiol. 2012 Feb;45(1):153-72. doi: 10.1007/s12035-011-8228-7. Epub 2011 Dec 27.

Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression

Bradley MA, Xiong-Fister S, Markesbery WR, Lovell MA.

Neurobiol Aging. 2012 Jun;33(6):1034-44. doi: 10.1016/j.neurobiolaging.2010.08.016. Epub 2010 Oct 20.

Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease

Salmon DP.

Curr Top Behav Neurosci. 2012;10:187-212. doi: 10.1007/7854_2011_171.

Sex hormones, aging, and Alzheimer's disease

Barron AM, Pike CJ.

Front Biosci (Elite Ed). 2012 Jan 1;4(3):976-97. doi: 10.2741/E434.

Retrograde memory in cerebrovascular disease and Alzheimer's disease

Capruso DX, Hamsher Kd.

J Stroke Cerebrovasc Dis. 2012 May;21(4):265-74. doi: 10.1016/j.jstrokecerebrovasdis.2010.08.005. Epub 2011 Feb 1.

Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis

Dai L, Liu D, Guo H, Wang Y, Bai Y.

J Neurol. 2012 Mar;259(3):414-9. doi: 10.1007/s00415-011-6164-0. Epub 2011 Jul 12.

Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease

Swerdlow RH.

Antioxid Redox Signal. 2012 Jun 15;16(12):1434-55. doi: 10.1089/ars.2011.4149. Epub 2011 Sep 15.

Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Kokjohn TA, Maarouf CL, Roher AE.

Alzheimers Dement. 2012 Nov;8(6):574-83. doi: 10.1016/j.jalz.2011.05.2429. Epub 2011 Nov 2.

Mouse models of Alzheimer's disease

Hall AM, Roberson ED.

Brain Res Bull. 2012 May 1;88(1):3-12. doi: 10.1016/j.brainresbull.2011.11.017. Epub 2011 Nov 28.

Brain insulin signaling and Alzheimer's disease: current evidence and future directions

Schiöth HB, Craft S, Brooks SJ, Frey WH 2nd, Benedict C.

Mol Neurobiol. 2012 Aug;46(1):4-10. doi: 10.1007/s12035-011-8229-6. Epub 2011 Dec 29.

Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome

Chace C, Pang D, Weng C, Temkin A, Lax S, Silverman W, Zigman W, Ferin M, Lee JH, Tycko B, Schupf N.

J Alzheimers Dis. 2012;28(3):601-12. doi: 10.3233/JAD-2011-110860.

RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease

Yan SS, Chen D, Yan S, Guo L, Du H, Chen JX.

Front Biosci (Schol Ed). 2012 Jan 1;4(1):240-50. doi: 10.2741/s265.